المصدر: Generics Industry Profile: France. Dec2024, p1-41. 41p.

مصطلحات موضوعية: GENERIC drugs

مصطلحات جغرافية: FRANCE

الشركة/الكيان: NOVARTIS AG 001221845 NVS, TEVA Pharmaceutical Industries Ltd. , SANOFI SA

المصدر: Generics Industry Profile: Europe. Dec2024, p1-47. 47p.

مصطلحات موضوعية: GENERIC drugs

مصطلحات جغرافية: EUROPE

الشركة/الكيان: NOVARTIS AG 001221845 NVS, HIKMA Pharmaceuticals PLC , SANOFI SA

المصدر: Generics Industry Profile: Russia. Dec2024, p1-36. 36p.

مصطلحات موضوعية: GENERIC drugs

مصطلحات جغرافية: RUSSIA

الشركة/الكيان: NOVARTIS AG 001221845 NVS, R-Pharm (Company) , BIOCAD (Company)

المصدر: Novartis AG SWOT Analysis. 9/27/2024, p1-7. 7p.

مصطلحات موضوعية: *PHARMACEUTICAL industry, *SWOT analysis

مصطلحات جغرافية: BASEL (Switzerland)

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المصدر: Novartis AG MarketLine Company Profile. 9/27/2024, p1-68. 68p.

مصطلحات موضوعية: *PHARMACEUTICAL biotechnology industry

مصطلحات جغرافية: SWITZERLAND

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المصدر: Novartis AG SWOT Analysis. 12/4/2023, p1-7. 7p.

مصطلحات موضوعية: *PHARMACEUTICAL industry, *SWOT analysis

مصطلحات جغرافية: BASEL (Switzerland)

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المصدر: Novartis AG MarketLine Company Profile. 12/4/2023, p1-69. 69p.

مصطلحات موضوعية: *PHARMACEUTICAL biotechnology industry

مصطلحات جغرافية: SWITZERLAND

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المصدر: Biotechnology Industry Profile: Europe. Feb2024, p1-49. 49p.

مصطلحات موضوعية: *BIOTECHNOLOGY industries

مصطلحات جغرافية: EUROPE

الشركة/الكيان: NOVARTIS AG 001221845 NVS, ASTRAZENECA PLC AZN, BAYER AG , BIONTECH SE

المؤلفون: IANSITI, MARCO, NADELLA, SATYA

المصدر: Harvard Business Review. May/Jun2022, Vol. 100 Issue 3, p42-49. 8p. 2 Color Photographs, 2 Graphs.

مصطلحات موضوعية: *CHANGE management, *ARTIFICIAL intelligence in business, *LEADERSHIP, DIGITAL technology

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المصدر: Biotechnology Industry Profile: Europe. Sep2023, p1-50. 50p.

مصطلحات موضوعية: *BIOTECHNOLOGY industries

مصطلحات جغرافية: EUROPE

الشركة/الكيان: NOVARTIS AG 001221845 NVS, BAYER AG , ASTRAZENECA PLC AZN, BIONTECH SE

المصدر: Pharmaceuticals Industry Profile: United Kingdom. Oct2023, p1-50. 50p.

مصطلحات موضوعية: *PHARMACEUTICAL industry

مصطلحات جغرافية: UNITED Kingdom

الشركة/الكيان: NOVARTIS AG 001221845 NVS, GLAXOSMITHKLINE , ASTRAZENECA PLC AZN

المصدر: Pharmaceuticals Industry Profile: Germany. Oct2023, p1-48. 48p.

مصطلحات موضوعية: *PHARMACEUTICAL industry

مصطلحات جغرافية: GERMANY

الشركة/الكيان: NOVARTIS AG 001221845 NVS, BAYER AG , BOEHRINGER Ingelheim GmbH

المؤلفون: FREIFELD, LORRI (AUTHOR)

المصدر: Training. May2024, Vol. 61 Issue 2, p35-41. 7p. 39 Color Photographs.

مصطلحات موضوعية: *CREDIT unions, GENERATIVE artificial intelligence

الشركة/الكيان: APPLIED Materials Inc. AMAT, NOVARTIS AG 001221845 NVS

المؤلفون: Kaltwasser, Jared

المصدر: Managed Healthcare Executive. Nov2024, Vol. 34 Issue 11, p12-16. 5p.

مصطلحات موضوعية: *MANAGED care programs, PLANNING techniques, MANTLE cell lymphoma

الشركة/الكيان: UNITED States. Food & Drug Administration , NOVARTIS AG 001221845 NVS

المؤلفون: Tang, Zhiwei¹ (AUTHOR), Chu, Shaojie¹ (AUTHOR), Wu, Xuesong¹ (AUTHOR) aomori_vale@163.com, Chen, Shaoxin¹ (AUTHOR), Chen, Likuo¹ (AUTHOR), Tang, Jiawei¹ (AUTHOR) 19111030056@fudan.edu.cn, Wang, Hongbo¹ (AUTHOR) 19111030056@fudan.edu.cn

المصدر: Molecules. May2024, Vol. 29 Issue 10, p2289. 16p.

مصطلحات موضوعية: *CLINICAL trials, *ENANTIOMERIC purity, *BENZYL compounds, *COMPLEMENT inhibition, *SITE-specific mutagenesis

الشركة/الكيان: UNITED States. Food & Drug Administration , NOVARTIS AG 001221845 NVS

المؤلفون: Emmett, Louise^1,2,3 (AUTHOR) louise.emmett@svha.org.au, Subramaniam, Shalini^4,5 (AUTHOR), Crumbaker, Megan^1,2,3,6,7 (AUTHOR), Nguyen, Andrew^1,2 (AUTHOR), Joshua, Anthony M^3,6 (AUTHOR), Weickhardt, Andrew^8,9 (AUTHOR), Lee, Sze-Ting^9,10,11,12 (AUTHOR), Ng, Siobhan^13,14 (AUTHOR), Francis, Roslyn J^15,16 (AUTHOR), Goh, Jeffrey C^17,18 (AUTHOR), Pattison, David A^19,20 (AUTHOR), Tan, Thean Hsiang²¹ (AUTHOR), Kirkwood, Ian D^22,23 (AUTHOR), Gedye, Craig²⁴ (AUTHOR), Rutherford, Natalie K²⁵ (AUTHOR), Sandhu, Shahneen^26,27 (AUTHOR), Kumar, Aravind Ravi²⁷ (AUTHOR), Pook, David²⁸ (AUTHOR), Ramdave, Shakher²⁹ (AUTHOR), Nadebaum, David P³⁰ (AUTHOR)

المصدر: Lancet Oncology. May2024, Vol. 25 Issue 5, p563-571. 9p.

مصطلحات موضوعية: *CASTRATION-resistant prostate cancer, *ANDROGEN receptors, *ABIRATERONE acetate

مصطلحات جغرافية: SAINT Vincent

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المؤلفون: Kostromina, Maria A.¹ (AUTHOR), Tukhovskaya, Elena A.² (AUTHOR) tukhovsksya@bibch.ru, Shaykhutdinova, Elvira R.² (AUTHOR), Palikova, Yuliya A.² (AUTHOR), Palikov, Viktor A.² (AUTHOR), Slashcheva, Gulsara A.² (AUTHOR), Ismailova, Alina M.² (AUTHOR), Kravchenko, Irina N.² (AUTHOR), Dyachenko, Igor A.² (AUTHOR), Zayats, Evgeniy A.¹ (AUTHOR), Abramchik, Yuliya A.¹ (AUTHOR), Murashev, Arkady N.² (AUTHOR), Esipov, Roman S.¹ (AUTHOR)

المصدر: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3986. 16p.

مصطلحات موضوعية: *ANTICOAGULANTS, *HEPARIN, *VENA cava inferior, *VENOUS thrombosis, *FIBRINOLYTIC agents, *COMPARATIVE method

مصطلحات جغرافية: BASEL (Switzerland)

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المؤلفون: de Latour, R. Peffault^1,2,3 regis.peffaultdelatour@aphp.fr, Roth, A.⁴, Kulasekararaj, A. G.^3,5,6,7, Han, B., Scheinberg, P., Maciejewski, J. P.⁸, Ueda, Y.⁹, de Castro, C. M.¹⁰, Di Bona, E.¹¹, Fu, R.¹², Zhang, L.¹³, Griffin, M.^3,14, Langemeijer, S. M. C.¹⁵, Panse, J.¹⁶, Schrezenmeier, H.¹⁷, Barcellini, W.^3,18, Mauad, V. A. Q.¹⁹, Schafhausen, P.²⁰, Tavitian, S.^3,21, Beggiato, E.²²

المصدر: New England Journal of Medicine. 3/14/2024, Vol. 390 Issue 11, p994-1008. 15p.

مصطلحات موضوعية: *PAROXYSMAL hemoglobinuria, *CLINICAL trials, *COMPLEMENT inhibition, *HEMOLYTIC anemia, *LACTATE dehydrogenase

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المؤلفون: van Rijt-Weetink, Yrea R. J.^1,2 (AUTHOR), Egberts, Toine C. G.^3,4 (AUTHOR), van Hunsel, Florence P. A. M.^1,2 (AUTHOR), Lewis, David J.^5,6 (AUTHOR), Yates, Laura M.^7,8 (AUTHOR), Winterfeld, Ursula⁹ (AUTHOR), van Puijenbroek, Eugène P.^1,2 (AUTHOR) e.vanpuijenbroek@lareb.nl

المصدر: Drug Safety. Mar2024, Vol. 47 Issue 3, p261-270. 10p.

مصطلحات موضوعية: *PREGNANCY, *RECEIVER operating characteristic curves, *JUDGMENT (Psychology)

مصطلحات جغرافية: SWITZERLAND

الشركة/الكيان: NOVARTIS AG 001221845 NVS

المؤلفون: Favre, Guillaume^1,2 (AUTHOR), Richardson, Jonathan L.^3,4 (AUTHOR), Moore, Alan⁵ (AUTHOR), Geissbühler, Yvonne⁵ (AUTHOR), Jehl, Valentine⁵ (AUTHOR), Oliver, Alison³ (AUTHOR), Shechtman, Svetlana⁶ (AUTHOR), Diav-Citrin, Orna⁶ (AUTHOR), Berlin, Maya⁷ (AUTHOR), De Haan, Tal⁷ (AUTHOR), Baud, David² (AUTHOR), Panchaud, Alice^8,9 (AUTHOR), Mor, Anil¹⁰ (AUTHOR), Sabidó, Meritxell¹¹ (AUTHOR), de Souza, Sabrina¹¹ (AUTHOR), Chambers, Christina¹² (AUTHOR), van Rijt-Weetink, Yrea R. J.¹³ (AUTHOR), van Puijenbroek, Eugène P.¹³ (AUTHOR), Yates, Laura M.^14,15 (AUTHOR), Girardin, François¹ (AUTHOR)

المصدر: Drug Safety. Mar2024, Vol. 47 Issue 3, p227-236. 10p.

مصطلحات موضوعية: *DISTRIBUTED computing, *PREGNANCY, *PREGNANCY outcomes, *ACQUISITION of data, *DATA collection platforms, *INFORMATION professionals

مصطلحات جغرافية: JERUSALEM

الشركة/الكيان: SANOFI SA , NOVARTIS AG 001221845 NVS